| Financial Year |
March 31 2023 |
| Monetary Funds |
450,444,949.27 |
| Held-for-trading Financial Assets |
5,580,286.81 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,010,939,094.51 |
| Advances to Suppliers |
42,700,872.82 |
| Other Receivables |
30,533,732.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
438,194,112.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,000,000.00 |
| Other Current Assets |
14,777,557.23 |
| Total Current Assets |
2,003,736,403.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,574,158.08 |
| Long-term Equity Investment |
406,535,234.78 |
| Investment Properties |
-- |
| Fixed Assetes |
1,140,631,107.17 |
| Under-construction Projects |
75,809,033.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
237,489,677.09 |
| R&D expenses |
462,526.16 |
| Goodwill |
204,909,870.90 |
| Long-Term Deferred and Prepaid Expenses |
6,610,812.96 |
| Deferred Income Tax Assets |
11,397,980.64 |
| Other Non-Current Assets |
27,883,934.32 |
| Sub-Total of Non-Current Assets |
2,165,098,234.81 |
| Total Assets |
4,168,834,638.58 |
| Short-Term Loans |
706,490,977.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
62,250,275.09 |
| Accounts Payable |
314,370,188.24 |
| Accounts Received In Advance |
900.00 |
| Employee Compensation Payable |
50,924,356.56 |
| Taxes Payable |
31,361,025.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
127,289,321.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,404,542.31 |
| Other Current Liabilities |
1,653,779.61 |
| Sub-Total of Current Liabilities |
1,342,302,177.98 |
| Long-term Loans |
60,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
17,568,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,963,652.25 |
| Deferred Income Tax Liabilities |
21,555,771.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
165,954,130.72 |
| Total Liabilities |
1,508,256,308.70 |
| Paid-In Capital(Or Share Stock) |
441,569,000.00 |
| Capital Surplus |
621,566,358.26 |
| Surplus Reserve |
96,017,911.45 |
| LESS:Treasury Stock |
99,160,206.15 |
| Undistributed Profits |
1,262,210,292.67 |
| Minority Stockholder's Interest |
336,506,461.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,324,071,868.10 |
| Owner's Equity（Stockholder's Equity） |
2,660,578,329.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,168,834,638.58 |
